生物标志物
生物标志物发现
免疫系统
2019年冠状病毒病(COVID-19)
计算生物学
医学
疾病
免疫学
生物
内科学
传染病(医学专业)
蛋白质组学
生物化学
基因
作者
Jing Cao,Yan Xiao,Mengji Zhang,Lin Huang,Ying Wang,Wanshan Liu,Xinming Wang,Jiao Wu,Yida Huang,Ruimin Wang,Li Zhou,Lin Li,Yong Zhang,Lili Ren,Kun Qian,Wei Wang
出处
期刊:Small
[Wiley]
日期:2022-12-05
卷期号:19 (7)
被引量:5
标识
DOI:10.1002/smll.202206349
摘要
Abstract Infection classification is the key for choosing the proper treatment plans. Early determination of the causative agents is critical for disease control. Host responses analysis can detect variform and sensitive host inflammatory responses to ascertain the presence and type of the infection. However, traditional host‐derived inflammatory indicators are insufficient for clinical infection classification. Fingerprints‐based omic analysis has attracted increasing attention globally for analyzing the complex host systemic immune response. A single type of fingerprints is not applicable for infection classification (area under curve (AUC) of 0.550–0.617). Herein, an infection classification platform based on deep learning of dual plasma fingerprints (DPFs‐DL) is developed. The DPFs with high reproducibility (coefficient of variation <15%) are obtained at low sample consumption (550 nL native plasma) using inorganic nanoparticle and organic matrix assisted laser desorption/ionization mass spectrometry. A classifier (DPFs‐DL) for viral versus bacterial infection discrimination (AUC of 0.775) and coronavirus disease 2019 (COVID‐2019) diagnosis (AUC of 0.917) is also built. Furthermore, a metabolic biomarker panel of two differentially regulated metabolites, which may serve as potential biomarkers for COVID‐19 management (AUC of 0.677–0.883), is constructed. This study will contribute to the development of precision clinical care for infectious diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI